SCHEMBL24124865

SCHEMBL24124865

CC(C)N1C(=O)CSc2ccc(C=O)cc21

nearest known ligand 0.40

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 2/20 0.40
▸ SMN1; SMN2 Q16637 3/20 0.38
▸ POLB P06746 2/20 0.38
▸ ALDH1A1 P00352 4/20 0.36
▸ ALDH1A3 P47895 4/20 0.36
▸ MEN1 O00255 5/20 0.34
▸ KMT2A Q03164 5/20 0.34
▸ MAPT P10636 4/20 0.34
▸ HTT P42858 2/20 0.34
▸ GAA P10253 1/20 0.34
▸ HPGD P15428 1/20 0.34
▸ NPSR1 Q6W5P4 1/20 0.34
▸ TYR P14679 1/20 0.33
▸ OPRM1 P35372 1/20 0.33
▸ OPRD1 P41143 1/20 0.33
▸ KCNN4 O15554 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24124853 0.77 LMNA (0.70) LMNASMN1; SMN2POLBALDH1A1MEN1
SCHEMBL5340775 0.71 ALDH1A1 (0.56) LMNASMN1; SMN2POLBALDH1A1MEN1
SCHEMBL24124962 0.68 MAPT (0.47) LMNASMN1; SMN2POLBALDH1A1MEN1
SCHEMBL8711321 0.66 BCHE (0.41) LMNASMN1; SMN2ALDH1A1ALDH1A3MEN1
SCHEMBL9920472 0.65 LMNA (0.58) LMNASMN1; SMN2POLBALDH1A1MEN1
SCHEMBL6177638 0.64 ALDH1A1 (0.49) SMN1; SMN2ALDH1A1ALDH1A3MEN1KMT2A
SCHEMBL622422 0.64 HTT (0.56) LMNAPOLBALDH1A1KMT2AHTT
SCHEMBL17821428 0.62 KMT2A (0.46) SMN1; SMN2POLBALDH1A1MEN1KMT2A
SCHEMBL14518825 0.62 MAPT (0.56) LMNASMN1; SMN2POLBALDH1A1MEN1
SCHEMBL10022341 0.62 ALDH1A1 (0.52) LMNAALDH1A1NPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021257544-A1 SOX11 INHIBITORS FOR TREATING MANTLE CELL LYMPHOMA ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI (US) 2021-12-23 — — WO disclosed
Send feedback